2010
DOI: 10.2298/vsp1011903d
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiological characteristics and clinical manifestations of acute non-A-E hepatitis

Abstract: Based on the results obtained in this study, it is probable that there are some so far undetected primary hepatotropic viruses in our environment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“…Cases with a clinical picture and biochemistry parameters suggestive of viral hepatitis with negative viral markers and no prior history of exposure to toxins and drugs are classifi ed as seronegative hepatitis. [18,19] Tests for metabolic disease Blood and urine samples are analyzed in the specialized laboratories of the National Medical Genetics Center (CNGM) to identify congenital errors of metabolism (alpha 1 antitrypsin defi ciency, galactosemia, tyrosinemia, Wilson disease, neonatal hemochromatosis, fatty acid beta-oxidation disorders and other enzyme defi ciencies). According to causal inference guidelines, toxic causes (carbon tetrachloride, halothane, and potentially hepatotoxic herbs and drugs) are excluded in the absence of immediate exposure or exposure up to six months prior to ALF onset.…”
Section: Data Collectionmentioning
confidence: 99%
“…Cases with a clinical picture and biochemistry parameters suggestive of viral hepatitis with negative viral markers and no prior history of exposure to toxins and drugs are classifi ed as seronegative hepatitis. [18,19] Tests for metabolic disease Blood and urine samples are analyzed in the specialized laboratories of the National Medical Genetics Center (CNGM) to identify congenital errors of metabolism (alpha 1 antitrypsin defi ciency, galactosemia, tyrosinemia, Wilson disease, neonatal hemochromatosis, fatty acid beta-oxidation disorders and other enzyme defi ciencies). According to causal inference guidelines, toxic causes (carbon tetrachloride, halothane, and potentially hepatotoxic herbs and drugs) are excluded in the absence of immediate exposure or exposure up to six months prior to ALF onset.…”
Section: Data Collectionmentioning
confidence: 99%
“…Hepatitis B has an incubation period ranging The 2nd International Meeting of Public Health 2016 from 6 weeks up to 6 months to clinical symptoms [7]. Hepatitis C has an incubation period of between 15-160 days, an average of about 50 days [8,16] (Safioleas & Manti 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Epidemiologic information related to non-A-E hepatitis is scarce. In a study by Delic et al 2010, analysing 408 patients with acute hepatitis, history of blood transfusion, drug use or other parenteral exposure were not associated with the onset of illness [ 7 ], suggesting that if the viral nature of non-A-E hepatitis is proven, it should spread primarily by non-parenteral means. Moreover, some patients diagnosed with acute non-A-E hepatitis show biochemical features at admission similar to those associated with other viral hepatitis.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, some patients diagnosed with acute non-A-E hepatitis show biochemical features at admission similar to those associated with other viral hepatitis. Apparently, acute non-A-E hepatitis is distributed worldwide, and progression to chronicity was observed in approximately 9% of patients [ 7 , 20 ].…”
Section: Introductionmentioning
confidence: 99%